Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1991-6-3
|
pubmed:language |
rus
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0235-2990
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
53-4
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2025121-Aminoglycosides,
pubmed-meshheading:2025121-Anti-Bacterial Agents,
pubmed-meshheading:2025121-Bacterial Infections,
pubmed-meshheading:2025121-Congresses as Topic,
pubmed-meshheading:2025121-Critical Care,
pubmed-meshheading:2025121-Cross Infection,
pubmed-meshheading:2025121-Europe,
pubmed-meshheading:2025121-Humans,
pubmed-meshheading:2025121-United States
|
pubmed:year |
1991
|
pubmed:articleTitle |
[Problems of using aminoglycosides in intensive therapy].
|
pubmed:publicationType |
Journal Article,
Comparative Study
|